foward pharm (FWP)

[TheFinalCD]

Forward Pharma A/S (NASDAQ: FWP) plummeted 30 percent Friday on news of Biogen Inc (NASDAQ: BIIB)’s patent victory over the active ingredient in their competing multiple sclerosis treatments. Biogen popped 1.5 percent on the news.

$BIIB wins Tecfidera patent interference against $FWP pic.twitter.com/TVeEX0TlR4

— Andy Biotech (@AndyBiotech) March 31, 2017

Forward had previously won a number of legal cases in the U.S. to prevent patent-infringement on dimethyl fumarate (DMF) and recently demanded royalties from Biogen for its Tecfidera. Following the battles, Biogen made a $1.25 billion bid to acquire the patent in January, but Forward refused to accept, prompting Biogen to pursue legal action. The latest ruling could free Biogen to market Tecfidera without restriction.
https://finance.yahoo.com/news/forward-pharma-falls-biogen-patent-161535412.html